Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.661, 2012-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Specialty hospitals increase revascularisation rates
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 524, 2007-01 ,pp. :
Access to resources
Recommend
Solifenacin economically dominant in OAB
Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. :
OPAT programme `economically attractive'
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 295, 2001-01 ,pp. :
Solifenacin economically dominant in OAB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 563, 2008-01 ,pp. :
Solifenacin economically dominant in OAB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 521, 2007-01 ,pp. :